SEC 13F Intelligence

Continental Advisors LLC / TEVA

Continental Advisors LLC’s Teva Pharmaceutical Inds Ltd Position

Does Continental Advisors LLC own Teva Pharmaceutical Inds Ltd (TEVA)? Yes — 242.1K shares worth $7M (+3.72% of its 13F portfolio) as of Q1 2026, down from 288.1K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
242.1K
% of Portfolio
+3.72%
Quarters Held
30
currently held

Position History TEVA

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $3MQ2 ’19: $2MQ3 ’19: $1MQ4 ’19: $2MQ4 ’19Q1 ’20: $1MQ2 ’20: $2MQ3 ’20: $1MQ4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ3 ’21: $3MQ4 ’21: $2MQ4 ’21Q1 ’22: $3MQ2 ’22: $2MQ3 ’22: $1MQ4 ’22: $3MQ4 ’22Q1 ’23: $3MQ2 ’23: $3MQ3 ’23: $3MQ4 ’23: $3MQ4 ’23Q1 ’24: $7MQ2 ’24: $7MQ3 ’24: $7MQ4 ’24: $8MQ4 ’24Q1 ’25: $5MQ2 ’25: $6MQ3 ’25: $7MQ4 ’25: $9MQ4 ’25Q1 ’26: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026242.1K$7M+3.72%
Q4 2025288.1K$9M+3.80%
Q3 2025341.1K$7M+2.98%
Q2 2025341.1K$6M+2.68%
Q1 2025341.1K$5M+2.93%
Q4 2024341.1K$8M+3.46%
Q3 2024361.6K$7M+3.14%
Q2 2024403.8K$7M+2.88%
Q1 2024477.8K$7M+2.72%
Q4 2023314.9K$3M+1.28%
Q3 2023340.9K$3M+1.85%
Q2 2023413.4K$3M+1.41%
Q1 2023369.8K$3M+1.75%
Q4 2022306.3K$3M+1.46%
Q3 2022175.3K$1M+0.83%
Q2 2022253.5K$2M+1.15%
Q1 2022278.5K$3M+1.29%
Q4 2021288.5K$2M+0.97%
Q3 2021288.5K$3M+1.19%
Q2 2021259.5K$3M+1.18%
Q1 2021249.5K$3M+1.33%
Q4 2020259.5K$3M+1.14%
Q3 2020133.2K$1M+0.64%
Q2 2020163.2K$2M+1.08%
Q1 2020163.2K$1M+1.09%
Q4 2019163.2K$2M+0.77%
Q3 2019171.2K$1M+0.70%
Q2 2019171.2K$2M+0.89%
Q1 2019171.2K$3M+1.25%
Q4 2018230.3K$4M+1.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Continental Advisors LLC’s full portfolio or all institutional holders of TEVA.